KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment.

Zeitouni, Daniel; Pylayeva-Gupta, Yuliya; Der, Channing J; Bryant, Kirsten L

Zeitouni, Daniel; Pylayeva-Gupta, Yuliya; Der, Channing J; Bryant, Kirsten L.

Afiliação

Zeitouni D; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. dzeitoun@live.unc.edu.
Pylayeva-Gupta Y; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. yuliyap1@email.unc.edu.
Der CJ; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. cjder@med.unc.edu.
Bryant KL; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. bryantkl@email.unc.edu.

Cancers (Basel) ; 8(4)2016 Apr 18.

Article em En | MEDLINE | ID: mdl-27096871

Palavras-chave

RAS; cancer; pancreatic; therapeutics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google